Year |
Citation |
Score |
2016 |
Beckerman R, Yoh K, Mattia-Sansobrino M, Zupnick A, Laptenko O, Karni-Schmidt O, Ahn J, Byeon IJ, Keezer S, Prives C. Lysines in the tetramerization domain of p53 selectively modulate G1 arrest. Cell Cycle (Georgetown, Tex.). 1-14. PMID 27210019 DOI: 10.1080/15384101.2016.1170270 |
0.818 |
|
2012 |
Barsotti AM, Beckerman R, Laptenko O, Huppi K, Caplen NJ, Prives C. p53-Dependent induction of PVT1 and miR-1204. The Journal of Biological Chemistry. 287: 2509-19. PMID 22110125 DOI: 10.1074/Jbc.M111.322875 |
0.788 |
|
2011 |
Huggins P, Zhong S, Shiff I, Beckerman R, Laptenko O, Prives C, Schulz MH, Simon I, Bar-Joseph Z. DECOD: fast and accurate discriminative DNA motif finding. Bioinformatics (Oxford, England). 27: 2361-7. PMID 21752801 DOI: 10.1093/Bioinformatics/Btr412 |
0.443 |
|
2011 |
Laptenko O, Beckerman R, Freulich E, Prives C. p53 binding to nucleosomes within the p21 promoter in vivo leads to nucleosome loss and transcriptional activation. Proceedings of the National Academy of Sciences of the United States of America. 108: 10385-90. PMID 21606339 DOI: 10.1073/Pnas.1105680108 |
0.796 |
|
2011 |
Poyurovsky MV, Katz C, Laptenko O, Beckerman R, Lokshin M, Ahn J, Byeon IL, Gabizon R, Mattia M, Zupnick A, Brown LM, Friedler A, Prives C. Erratum: The C terminus of p53 binds the N-terminal domain of MDM2 Nature Structural & Molecular Biology. 18: 516-516. DOI: 10.1038/Nsmb0411-516C |
0.719 |
|
2010 |
Beckerman R, Prives C. Transcriptional regulation by p53. Cold Spring Harbor Perspectives in Biology. 2: a000935. PMID 20679336 DOI: 10.1101/Cshperspect.A000935 |
0.734 |
|
2010 |
Poyurovsky MV, Katz C, Laptenko O, Beckerman R, Lokshin M, Ahn J, Byeon IJ, Gabizon R, Mattia M, Zupnick A, Brown LM, Friedler A, Prives C. The C terminus of p53 binds the N-terminal domain of MDM2. Nature Structural & Molecular Biology. 17: 982-9. PMID 20639885 DOI: 10.1038/Nsmb.1872 |
0.781 |
|
2010 |
Prives C, Barsotti AM, Beckerman R, Biderman L, Laptenko O, Mattia M, Tanaka T, Singer S, Zupnick A. 636 Mechanisms by which the p53 tumour suppressor protein selects its target genes Ejc Supplements. 8: 161. DOI: 10.1016/S1359-6349(10)71436-1 |
0.791 |
|
2009 |
Beckerman R, Donner AJ, Mattia M, Peart MJ, Manley JL, Espinosa JM, Prives C. A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpoint. Genes & Development. 23: 1364-77. PMID 19487575 DOI: 10.1101/Gad.1795709 |
0.824 |
|
2009 |
Ahn J, Poyurovsky MV, Baptiste N, Beckerman R, Cain C, Mattia M, McKinney K, Zhou J, Zupnick A, Gottifredi V, Prives C. Dissection of the sequence-specific DNA binding and exonuclease activities reveals a superactive yet apoptotically impaired mutant p53 protein. Cell Cycle (Georgetown, Tex.). 8: 1603-15. PMID 19462533 DOI: 10.4161/Cc.8.10.8548 |
0.665 |
|
2007 |
Karni-Schmidt O, Friedler A, Zupnick A, McKinney K, Mattia M, Beckerman R, Bouvet P, Sheetz M, Fersht A, Prives C. Energy-dependent nucleolar localization of p53 in vitro requires two discrete regions within the p53 carboxyl terminus. Oncogene. 26: 3878-91. PMID 17237827 DOI: 10.1038/Sj.Onc.1210162 |
0.725 |
|
Show low-probability matches. |